CHINA PHARMA HOLDINGS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

CHINA PHARMA HOLDINGS, INC. reported Cash And Cash Equivalents At Carrying Value of $1.42 million for the year ending 2023.

  • CHINA PHARMA HOLDINGS, INC. showed a decrease of -29.9% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from CHINA PHARMA HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 1, 2024.
  • XBRL data for this metric is available from 2009 to 2023 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2010: $4.56 million | Q1 2011: $3.80 million | Q2 2011: $4.69 million | Q3 2011: $4.85 million | Q4 2011: $4.05 million | Q1 2012: $3.32 million | Q2 2012: $4.87 million | Q3 2012: $5.06 million | Q4 2012: $4.03 million | Q1 2013: $4.75 million | Q2 2016: $6.29 million | Q3 2016: $3.65 million | Q1 2017: $2.52 million | Q2 2017: $1.75 million | Q3 2017: $1.12 million | Q4 2017: $2.03 million | Q1 2018: $2.47 million | Q2 2018: $1.94 million | Q3 2018: $667.6 thousand | Q1 2019: $961.3 thousand | Q2 2019: $1.66 million | Q3 2019: $761.6 thousand | Q1 2020: $145.9 thousand | Q2 2020: $1.81 million | Q3 2020: $346.6 thousand | Q1 2021: $534.5 thousand | Q2 2021: $1.75 million | Q3 2021: $458.8 thousand | Q1 2022: $3.71 million | Q2 2022: $2.24 million | Q3 2022: $2.09 million | Q1 2023: $1.17 million | Q2 2023: $901.9 thousand | Q3 2023: $1.37 million | Q4 2024: $626.9 thousand | Q3 2025: $267.6 thousand.
  • Over the full 13 years of available data (2009 to 2023), CHINA PHARMA HOLDINGS, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 60.8%.
  • Historical annual values: Fiscal year 2023: $1.42 million | Fiscal year 2022: $2.03 million | Fiscal year 2021: $4.86 million | Fiscal year 2020: $957.7 thousand | Fiscal year 2019: $1.07 million | Fiscal year 2018: $1.19 million | Fiscal year 2017: $2.03 million | Fiscal year 2016: $2.67 million | Fiscal year 2015: $6.25 million | Fiscal year 2012: $4.03 million | Fiscal year 2011: $4.05 million | Fiscal year 2010: $3.69 million | Fiscal year 2009: $3.63 million.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: